Faithward Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,072
Closed -$546K 269
2021
Q1
$546K Buy
+6,072
New +$570K 0.12% 94
2020
Q4
Sell
-39,316
Closed -$4.05M 140
2020
Q3
$4.05M Buy
39,316
+2,692
+7% +$281K 0.98% 34
2020
Q2
$3.71M Buy
+36,624
New +$3.28M 0.96% 39

Other funds holding DXCM

Faithward Advisors's DXCM Position: Q2 2021 in Review

Faithward Advisors sold out of DexCom (DXCM) in Q2 2021, closing a stake of 6,072 shares — an estimated $546K sold.

Faithward Advisors first reported a position in DXCM in Q2 2020 and held it in 3 quarters. The position peaked at $4.05M in Q3 2020. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Faithward Advisors reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Faithward Advisors sold 6,072 DexCom shares in Q2 2021, an estimated $546K.
  • Faithward Advisors first reported a position in DexCom in Q2 2020 and held it in 3 quarters.
  • Faithward Advisors's DexCom position peaked at $4.05M in Q3 2020.
  • 726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Faithward Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.